13F-HR filed by SIT INVESTMENT ASSOCIATES INC
SIT INVESTMENT ASSOCIATES INC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-12, with 506 holding rows worth $4,998,638,000.
- Accession
- 0000897101-26-000038
- Filer
- CIK 769317
- Filed
- 2026-02-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 506 entries on the cover page, a total value of $4,998,638,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,998,638,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-00180. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSIT FIXED INCOME ADVISORS II LLC /ADV028-19972
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MasterCard, Inc | 57636Q104 | COM | 22 | $13,000 | thousands, detected and multiplied | |
| TRUIST FINL CORP COM | 89832Q109 | Stock | 125 | $6,000 | thousands, detected and multiplied | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 272 | $2,000 | thousands, detected and multiplied | |
| OUTSET MED INC | 690145206 | COM NEW | 177 | $1,000 | thousands, detected and multiplied | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 970 | $0 | thousands, detected and multiplied | Value filed as zero, left out of ratios. |
| TETRALOGIC PHARMACEUTICALS COR | 88165U109 | COMMON | 3,913 | $0 | thousands, detected and multiplied | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000897101-26-000038 | this filing | 2026-02-12 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000897101-26-000074 | added | 2026-02-25 | acceptance time not in the bulk data set |